Directori de persones
Milica Bozic

Milica Bozic

Grau: Doctor/a

973 70 29 52 / 2212
mbozic(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/B-7425-2009

Publicacions

  • Bozic, Milica; Diaz-Tocados, Juan M.; Bermudez-Lopez, Marcelino; Forne, Carles; Martinez, Cristina; Fernandez, Elvira; Valdivielso, Jose M.

    Independent effects of secondary hyperparathyroidism and hyperphosphatemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort.

    NEPHROLOGY DIALYSIS TRANSPLANTATION 37 1-10. .

    [doi:10.1093/ndt/gfab184]

  • Kosanovic M; Llorente A; Glamoclija S; Valdivielso JM; Bozic M

    Extracellular Vesicles and Renal Fibrosis: An Odyssey toward a New Therapeutic Approach.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 22 -. .

    [doi:10.3390/ijms22083887]

  • Cambray S; Bermudez-Lopez M; Bozic M; Valdivielso JM; NEFRONA investigators

    Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease.

    CLINICAL KIDNEY JOURNAL 13 1017-1024. .

    [doi:10.1093/ckj/sfaa014]

  • Bermudez-Lopez, M; Forne, C; Cambray, S; Bozic, M; Valdivielso, JM

    OUTCOMES AND HEALTHCARE RESOURCES UTILIZATION DIFFERENCES IN PATIENTS WITH AND WITHOUT SECONDARY HYPERPARATHYROIDISM FROM THE NEFRONA COHORT

    VALUE IN HEALTH 23 753-753. .

  • Matsushita K; Jassal SK; Sang Y; Ballew SH; Grams ME; Surapaneni A; Arnlov J; Bansal N; Bozic M; Brenner H; Brunskill NJ; Chang AR; Chinnadurai R; Cirillo M; Correa A; Ebert N; Eckardt KU; Gansevoort RT; Gutierrez O; Hadaegh F; He J; Hwang SJ; Jafar TH; Kayama T; Kovesdy CP; Landman GW; Levey AS; Lloyd-Jones DM; Major RW; Miura K; Muntner P; Nadkarni GN; Naimark DM; Nowak C; Ohkubo T; Pena MJ; Polkinghorne KR; Sabanayagam C; Sairenchi T; Schneider MP; Shalev V; Shlipak M; Solbu MD; Stempniewicz N; Tollitt J; Valdivielso JM; van der Leeuw J; Wang AY; Wen CP; Woodward M; Yamagishi K; Yatsuya H; Zhang L; Schaeffner E; Coresh J

    Incorporating kidney disease measures into cardiovascular risk prediction: Development and validation in 9 million adults from 72 datasets.

    Eclinicalmedicine 27 100552-100552. .

    [doi:10.1016/j.eclinm.2020.100552]

  • Cambray S; Ibarz M; Bermudez-Lopez M; Marti-Antonio M; Bozic M; Fernandez E; Valdivielso JM

    Magnesium Levels Modify the Effect of Lipid Parameters on Carotid Intima Media Thickness.

    Nutrients 12 1-12. .

    [doi:10.3390/nu12092631]

  • Valdivielso, JM; Eritja À; Caus, M; Bozic, M

    Glutamate-Gated NMDA Receptors: Insights into the Function and Signaling in the Kidney.

    Biomolecules 10 1-18. .

    [doi:10.3390/biom10071051]

  • Bozic, M; Caus, M; Rodrigues-Diez, RR; Pedraza, N; Ruiz-Ortega, M; Gari, E; Gallel, P; Panades, MJ; Martinez, A; Fernandez, E; Valdivielso, JM

    Protective role of renal proximal tubular alpha-synuclein in the pathogenesis of kidney fibrosis.

    Nature Communications 11 1943-1943. .

    [doi:10.1038/s41467-020-15732-9]

  • Valdivielso JM; Bozic M; Galimudi RK; Bermudez-López M; Navarro-González JF; Fernández E; Betriu À

    Association of the rs495392 Klotho polymorphism with atheromatosis progression in patients with chronic kidney disease

    NEPHROLOGY DIALYSIS TRANSPLANTATION 34 2079-2088. .

    [doi:10.1093/ndt/gfy207]

  • Forné, Carles; Cambray, Serafi; Bermudez-Lopez, Marcelino; Fernandez, Elvira; Bozic, Milica; Valdivielso, Jose M

    Machine learning analysis of serum biomarkers for cardiovascular risk assessment in chronic kidney disease

    CLINICAL KIDNEY JOURNAL 13 631-639. .

    [doi:10.1093/ckj/sfz094]

  • Bermudez-Lopez M; Forne C; Amigo N; Bozic M; Arroyo D; Bretones T; Alonso N; Cambray S; Del Pino MD; Mauricio D; Gorriz JL; Fernandez E; Valdivielso JM

    An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients

    Expert Opinion On Therapeutic Targets 23 619-630. .

    [doi:10.1080/14728222.2019.1620206]

  • Bozic, M; Caus, M; Rodrigues-Diez, RR; Ruiz-Ortega, M; Martinez, A; Blasco, A; Gallel, P; Fernandez, E; Valdivielso, JM

    ALPHA-SYNUCLEIN MAINTAINS THE EPITHELIAL PHENOTYPE AND PROTECTS FROM RENAL FIBROSIS

    NEPHROLOGY DIALYSIS TRANSPLANTATION 34 156-156. .

Projectes

  • Unraveling the role of piwi-interacting RNAs in the pathogenesis of obesity-induced kidney disease. Identification of potential biomarkers and therapeutic targets (RENOPIWI)
  • Contratos predoctorales de formación en investigación en salud (PFIS)
  • Descifrando el papel de SNCA en la regulación de la autofagia y el daño renal: implicaciones mecanísticas, terapéuticas y pronósticas.
  • Contrato Miguel Servet - RRHH
  • Contrato Miguel Servet - Proyecto
  • Papel del receptor NMDA en el daño renal inducido por hiperlipidemia. Estudio de los mecanismos moleculares y posibles implicaciones terapéuticas
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA CIENTIFICA BASICA PER A LA CARACTERITZACIO D'UN PERFIL LIPIDOMICO Y LIPIDICO DE RIESGO ATEROGENERICO Y DE MORBIMORTALIDAD CARDIOVASCUAL EN LA ENFERMEDAD RENAL CRONICA (ESTADIOS 3 A 5), ESTUDIO PROSPECTIVO NEFRONA.
  • Papel de la expresión renal de alfa sinucleina en la enfermedad renal crónica. Implicaciones en la patogénesis de la fibrosis renal
  • IDENTIFYING PREDICTORS OF CARDIOVASCULAR EVENTS IN CHRONIC KIDNEY DISEASE. A COHORTS SUBSTUDY WITHIN THE NEFRONA STUDY
  • PAPEL DE LA FALTA DE VITAMINA D EN LA PROGRESION DE LA PLACA ATEROSCLEROTICA. IMPLICACIONES ENF LA ARTERIOPATIA UREMICA
  • PROGRAMA DE BEQUES PER A PERSONAL INVESTIGADOR NOVELL (FI)